These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

834 related items for PubMed ID: 27994460

  • 1. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
    Prabhakar N, Zhang J, Desai D, Casals E, Gulin-Sarfraz T, Näreoja T, Westermarck J, Rosenholm JM.
    Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
    [Abstract] [Full Text] [Related]

  • 2. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
    Li X, Chen Y, Wang M, Ma Y, Xia W, Gu H.
    Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
    [Abstract] [Full Text] [Related]

  • 3. Sustained delivery of siRNA/mesoporous silica nanoparticle complexes from nanofiber scaffolds for long-term gene silencing.
    Pinese C, Lin J, Milbreta U, Li M, Wang Y, Leong KW, Chew SY.
    Acta Biomater; 2018 Aug; 76():164-177. PubMed ID: 29890267
    [Abstract] [Full Text] [Related]

  • 4. Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.
    Lin D, Cheng Q, Jiang Q, Huang Y, Yang Z, Han S, Zhao Y, Guo S, Liang Z, Dong A.
    Nanoscale; 2013 May 21; 5(10):4291-301. PubMed ID: 23552843
    [Abstract] [Full Text] [Related]

  • 5. Endosomal escape kinetics of mesoporous silica-based system for efficient siRNA delivery.
    Wang M, Li X, Ma Y, Gu H.
    Int J Pharm; 2013 May 01; 448(1):51-7. PubMed ID: 23524121
    [Abstract] [Full Text] [Related]

  • 6. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X, Zhao Y, Ng KW, Zhao Y.
    Chemistry; 2013 Nov 11; 19(46):15593-603. PubMed ID: 24123533
    [Abstract] [Full Text] [Related]

  • 7. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications.
    Buchman YK, Lellouche E, Zigdon S, Bechor M, Michaeli S, Lellouche JP.
    Bioconjug Chem; 2013 Dec 18; 24(12):2076-87. PubMed ID: 24180511
    [Abstract] [Full Text] [Related]

  • 8. The packaging of siRNA within the mesoporous structure of silica nanoparticles.
    Li X, Xie QR, Zhang J, Xia W, Gu H.
    Biomaterials; 2011 Dec 18; 32(35):9546-56. PubMed ID: 21906804
    [Abstract] [Full Text] [Related]

  • 9. Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy.
    Wang Y, Xie Y, Kilchrist KV, Li J, Duvall CL, Oupický D.
    ACS Appl Mater Interfaces; 2020 Jan 29; 12(4):4308-4322. PubMed ID: 31939276
    [Abstract] [Full Text] [Related]

  • 10. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.
    Zhuang J, Chen S, Hu Y, Yang F, Huo Q, Xie N.
    Int J Nanomedicine; 2021 Jan 29; 16():1961-1976. PubMed ID: 33727809
    [Abstract] [Full Text] [Related]

  • 11. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.
    Lin JT, Liu ZK, Zhu QL, Rong XH, Liang CL, Wang J, Ma D, Sun J, Wang GH.
    Colloids Surf B Biointerfaces; 2017 Jul 01; 155():41-50. PubMed ID: 28407530
    [Abstract] [Full Text] [Related]

  • 12. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy.
    Hanafi-Bojd MY, Jaafari MR, Ramezanian N, Abnous K, Malaekeh-Nikouei B.
    Curr Drug Deliv; 2016 Jul 01; 13(7):1176-1182. PubMed ID: 26718488
    [Abstract] [Full Text] [Related]

  • 13. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW, Xiang B, Gao W, Yang ZZ, Li JQ, Qi XR.
    Biomaterials; 2013 Jul 01; 34(20):4849-59. PubMed ID: 23541420
    [Abstract] [Full Text] [Related]

  • 14. Unique Surface Modification of Silica Nanoparticles with Polyethylenimine (PEI) for siRNA Delivery Using Cerium Cation Coordination Chemistry.
    Kapilov-Buchman Y, Lellouche E, Michaeli S, Lellouche JP.
    Bioconjug Chem; 2015 May 20; 26(5):880-9. PubMed ID: 25830668
    [Abstract] [Full Text] [Related]

  • 15. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
    Ma X, Teh C, Zhang Q, Borah P, Choong C, Korzh V, Zhao Y.
    Antioxid Redox Signal; 2014 Aug 10; 21(5):707-22. PubMed ID: 23931896
    [Abstract] [Full Text] [Related]

  • 16. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
    Li N, Wang Z, Zhang Y, Zhang K, Xie J, Liu Y, Li W, Feng N.
    Artif Cells Nanomed Biotechnol; 2018 Aug 10; 46(sup2):921-935. PubMed ID: 29790797
    [Abstract] [Full Text] [Related]

  • 17. Biodegradable hybrid mesoporous silica nanoparticles for gene/chemo-synergetic therapy of breast cancer.
    Zhang B, Liu Q, Liu M, Shi P, Zhu L, Zhang L, Li R.
    J Biomater Appl; 2019 May 10; 33(10):1382-1393. PubMed ID: 30880565
    [Abstract] [Full Text] [Related]

  • 18. Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment.
    Wang D, Xu X, Zhang K, Sun B, Wang L, Meng L, Liu Q, Zheng C, Yang B, Sun H.
    Int J Nanomedicine; 2018 May 10; 13():187-198. PubMed ID: 29343957
    [Abstract] [Full Text] [Related]

  • 19. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape.
    Tu J, Wang T, Shi W, Wu G, Tian X, Wang Y, Ge D, Ren L.
    Biomaterials; 2012 Nov 10; 33(31):7903-14. PubMed ID: 22840227
    [Abstract] [Full Text] [Related]

  • 20. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M, Lipka J, Malek A, Gutsch D, Kreyling W, Aigner A.
    Eur J Pharm Biopharm; 2011 Apr 10; 77(3):438-49. PubMed ID: 21093588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.